Mylan Can't Revive Copaxone Antitrust Claims Against Teva
A New Jersey federal judge sided Monday with a special master's recommendations to nix some of the parallel claims from Mylan and retailers like Walgreens accusing Teva of using regulatory deception,...To view the full article, register now.
Already a subscriber? Click here to view full article